Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
European Journal of Clinical Investigation|April 11, 2023
Tocilizumab-related hypertriglyceridemia is independent of key molecules regulating lipid metabolismIván Ferraz-Amaro, Sergio Santos-Concepción, Javier Castro, et al.
Frontiers in Immunology|February 14, 2025
Tocilizumab modulates the activity of the classical and alternative complement pathways in rheumatoid arthritis patientsIván Ferraz-Amaro, Sergio Santos-Concepción, Javier Castro-Hernández, et al.
Clinical and Experimental Rheumatology|February 22, 2020
Reclassification into very-high cardiovascular risk after carotid ultrasound in patients with axial spondyloarthritisJavier Rueda-Gotor, Juan Carlos Quevedo-Abeledo, Alfonso Corrales, et al.
Arthritis Research & Therapy|February 24, 2021
HDL cholesterol efflux capacity and lipid profile in patients with systemic sclerosisIván Ferraz-Amaro, Esmeralda Delgado-Frías, Vanesa Hernández-Hernández, et al.
Clinical and Experimental Rheumatology|July 7, 2015
Relationship of abdominal adiposity and body composition with endothelial dysfunction in patients with rheumatoid arthritisEsmeralda Delgado-Frías, Miguel A González-Gay, Jose R Muñiz-Montes, et al.
Reumatologia Clinica|April 15, 2015
Adjustment in the clinical practice of treat-to-target guidelines for rheumatoid arthritis: Results of the ToARCan studyAntonio Naranjo, Laura Cáceres, José Ángel Hernández-Beriaín, et al.
Rheumatology International|August 5, 2015
Factors associated with the intensification of treatment in rheumatoid arthritis in clinical practiceAntonio Naranjo, Laura Cáceres, José Ángel Hernández-Beriaín, et al.
Seminars in Arthritis and Rheumatism|March 31, 2024
Combined use of QRISK3 and SCORE2 increases identification of ankylosing spondylitis patients at high cardiovascular risk: Results from the CARMA Project cohort after 7.5 years of follow-upJessica Polo Y la Borda, Santos Castañeda, Fernando Sánchez-Alonso, et al.
Arthritis Research & Therapy|June 27, 2012
Analysis of the association between CD40 and CD40 ligand polymorphisms and systemic sclerosisMaría Teruel, Carmen P Simeon, Jasper Broen, et al.
Clinical and Experimental Rheumatology|November 8, 2019
Association of apolipoprotein B/apolipoprotein A1 ratio and cardiovascular events in rheumatoid arthritis: results of the CARMA studySixto Zegarra-Mondragón, Ruth López-González, María Auxiliadora Martín-Martínez, et al.
Pageof 5